Virulizin immunomodulator: IMUTF (Toronto) said its planned Phase III trial of Virulizin would not take place until further study, perhaps in a Phase II trial,

IMUTEC Corp. (IMUTF)
Product: Virulizin immunomodulator
Indication:

Read the full 79 word article

How to gain access

Continue reading with a
two-week free trial.